stockrowArtivion, Inc. (AORT) vs NovoCure Limited (NVCR)
- Artivion, Inc. AORT 20.27 −19.98%
- NovoCure Limited NVCR 13.26 −2.14%
Artivion, Inc. and NovoCure Limited are both Medical Devices companies. NovoCure Limited is the larger, with a market value of $1.6B against $1.2B — 1.3× the size. Artivion, Inc. grew revenue faster over the last twelve months: 16.4% against 12.9%. Artivion, Inc. has the higher net margin (−0.67% vs −16.8%) and the higher return on invested capital (1.76% vs −106.1%). Across the 18 metrics below, Artivion, Inc. leads on 13 and NovoCure Limited on 5.
Valuation
Profitability
| Metric | AORT | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.37% | 77.02% | 57.76% |
| Operating margin | 4.38% | (17.17%) | (15.07%) |
| Net margin | (0.67%) | (16.78%) | (14.45%) |
| Free cash flow margin | (1.94%) | (3.39%) | (3.88%) |
| Return on equity | (0.73%) | (35.18%) | (10.35%) |
| Return on assets | (0.33%) | (11.12%) | (17.26%) |
| Return on invested capital | 1.76% | (106.10%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack